PortfoliosLab logo

ASLAN Pharmaceuticals Limited (ASLN)

Equity · Currency in USD · Last updated Nov 29, 2022

Company Info

ISINUS04522R1014
CUSIP04522R101
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.58
Year Range$0.36 - $1.50
EMA (50)$0.53
EMA (200)$0.73
Average Volume$216.80K
Market Capitalization$40.63M

ASLNShare Price Chart


Loading data...

ASLNPerformance

The chart shows the growth of $10,000 invested in ASLAN Pharmaceuticals Limited in May 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,038 for a total return of roughly -89.62%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovember
48.92%
-3.34%
ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNCompare to other instruments

Search for stocks, ETFs, and funds to compare with ASLN

ASLNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M45.63%1.61%
6M48.22%-4.67%
YTD-47.99%-16.83%
1Y-61.93%-13.73%
5Y-39.12%9.10%
10Y-39.12%9.10%

ASLNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-14.73%-9.95%4.65%-24.89%-40.24%22.52%-6.46%33.91%-3.39%-32.55%44.18%
202121.31%99.55%-24.38%-3.58%-8.05%11.11%-16.06%-3.61%-33.33%-5.62%-14.29%-22.22%
2020-1.48%-10.00%-43.33%64.96%4.60%13.64%-24.50%-0.00%25.83%-12.64%3.02%7.02%
2019-5.28%2.35%22.92%-10.72%-24.02%5.50%4.23%-48.13%4.22%-5.78%134.36%-46.86%
201847.24%7.75%-11.24%2.53%-1.48%-34.09%-3.23%-29.27%

ASLNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ASLAN Pharmaceuticals Limited Sharpe ratio is -0.76. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.76
-0.57
ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNDividend History


ASLAN Pharmaceuticals Limited doesn't pay dividends

ASLNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-94.31%
-17.36%
ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNWorst Drawdowns

The table below shows the maximum drawdowns of the ASLAN Pharmaceuticals Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ASLAN Pharmaceuticals Limited is 96.48%, recorded on Jun 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.48%Jun 8, 20181007Jun 7, 2022
-10.31%May 31, 20181May 31, 20182Jun 4, 20183
-7.38%May 14, 201810May 25, 20181May 29, 201811
-2.32%May 7, 20181May 7, 20181May 8, 20182
-0.4%Jun 6, 20181Jun 6, 20181Jun 7, 20182
-0.32%May 9, 20181May 9, 20182May 11, 20183

ASLNVolatility Chart

Current ASLAN Pharmaceuticals Limited volatility is 77.17%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovember
77.17%
14.31%
ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)